Data for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma (Study ST000916)
(Analysis AN001493)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 |
---|---|---|---|---|
CoQ-10 | 0.8833 | 1.2203 | 1.0732 | 0.7446 |
CoQ-9 | 0.8959 | 1.5859 | 0.8920 | 0.6302 |
Dolichol-17 | 0.7783 | 1.1514 | 0.9493 | 1.1750 |
Dolichol-18 | 1.1034 | 0.9809 | 0.9431 | 1.0046 |
Dolichol-19 | 1.0531 | 0.9761 | 1.0051 | 0.9562 |
Dolichol-20 | 0.8428 | 1.1517 | 1.0238 | 0.9631 |
Factors:
F1 | Diagnosis:Cirrhosis |
F2 | Diagnosis:NASH |
F3 | Diagnosis:Normal |
F4 | Diagnosis:Steatosis |